Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Alpha Cognition Inc C.ACOG

Alternate Symbol(s):  ACOG

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.


CSE:ACOG - Post by User

Post by partystockeron Sep 30, 2021 9:58am
132 Views
Post# 33942971

$ACOG.V's new treatment drug is one to watch

$ACOG.V's new treatment drug is one to watch

Science is advancing at a rapid rate. Some diseases that I thought would be permanently incurable, like Alzheimer’s, suddenly seem not to be. 


Yeah, u read that right- a treatment for Alzheimer’s is being developed by Alpha Cognition Inc. and it’s getting me super hyped. 


$ACOG.V has a drug candidate called Alpha 1062 thats on track to become the first safe and effective Alzheimer’s treatment in the world. 


The market $ACOG is in (biopharmaceuticals and Alzhiemer Disease treatment) is highly lucrative and in high demand. Like... on track to be a $19B market in the next 5 years kind of lucrative. The problem is, right now, the demand has not been filled. That’s where $ACOG comes in. 


The FDA has accepted Alpha 1062 as a candidate for clinical phase research, which is a huge step in $ACOG’s journey! Rn, this drug is on track to become incredibly lucrative as well as lifesaving, and $ACOG is 


This market is going to explode, and all my research shows that $ACOG is gearing up to be the front-runner of the whole industry. They’re already attracting a lot of investor attention… def my pick. 


Alpha Cognition Inc. is up today at $1.40 with a market cap of $72.58m. 


https://finance.yahoo.com/news/alpha-cognition-attracts-investors-future-163759282.html

 
<< Previous
Bullboard Posts
Next >>